ONL Therapeutics

NEWS

Deals

Money on the Move: January 12 – 18

Funds are always flowing in the life science industry. Here’s where the money’s headed this week.

January 18, 2022

·

2 min read

·

BioMidwest

Biopharma Money on the Move: December 16-22

A roundup of the latest biopharma companies scooping up cash through IPOs and financing rounds.

December 23, 2020

·

4 min read

·

IN THE PRESS

BioMidwest

ONL Therapeutics Receives Orphan Drug Designation For ONL1204 For Treatment Of Retinal Detachment From FDA

February 11, 2016

·

3 min read

BioMidwest

ONL Therapeutics To Present At The 2015 Ophthalmology Innovation Summit At American Academy of Ophthalmology Annual Meeting

October 30, 2015

·

3 min read

Business

ONL Therapeutics Announces Formation Of Scientific Advisory Board

October 15, 2015

·

6 min read

BioMidwest

ONL Therapeutics Provides Update On Novel Photoreceptor Protection Platform For Retinal Diseases

June 16, 2015

·

3 min read

BioMidwest

ONL Therapeutics To Present At Upcoming Investor And Scientific Conferences

March 16, 2015

·

2 min read

Business

ONL Therapeutics Announces Management Team Additions

December 3, 2014

·

4 min read

BioMidwest

ONL Therapeutics Receives Phase II National Eye Institute Grant From National Eye Institute For Development Of Novel Retinal Disease Treatment

November 12, 2014

·

3 min read

JOBS